Ticker Details
Reviva Pharmaceuticals Holdings, Inc.
IPO Date:	October 15, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$29.21M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.13 | 4.69%
Avg Daily Range (30 D):	$0.01 | 3.75%
Avg Daily Range (90 D):	$0.02 | 4.70%

Institutional Daily Volume
Avg Daily Volume:	1.32M
Avg Daily Volume (30 D):	2.67M
Avg Daily Volume (90 D):	5.52M

Trade Size
Avg Trade Size (Sh.):	389
Avg Trade Size (Sh.) (30 D):	765
Avg Trade Size (Sh.) (90 D):	734

Institutional Trades
Total Institutional Trades:	16
Avg Institutional Trade:	$.8M
Avg Institutional Trade (30 D):	$1.08M
Avg Institutional Trade (90 D):	$1.08M
Avg Institutional Trade Volume:	.38M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$.9M
Avg Closing Trade (30 D):	$1.08M
Avg Closing Trade (90 D):	$1.08M
Avg Closing Volume:	696.96K

News

Dec 29, 2025 @ 1:00 PM Reviva to Present at the Sachs 9th Annual Neurosci... Source: Not Specified

Oct 28, 2025 @ 12:00 PM Reviva to Present Negative Symptom Data for Brilar... Source: Reviva Pharmaceuticals Holdings, Inc.

Sep 19, 2025 @ 1:26 AM Reviva Pharmaceuticals Holdings, Inc. Announces Pr... Source: Reviva Pharmaceuticals Holdings, Inc.

May 1, 2025 @ 5:00 PM Schizophrenia Market to Witness Significant Growth... Source: Delveinsight

Jan 30, 2025 @ 1:00 PM Reviva to Participate in the 2025 BIO CEO & Invest... Source: N/A

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.06	$-.12	$-.13
Diluted EPS
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-4.01M	$-6.05M	$-6.43M
Operating Income / Loss	$-4.03M	$-6.07M	$-6.54M
Cost of Revenue
Net Cash Flow	$M	$M	$M
PE Ratio